Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
The current Johnson & Johnson(JNJ) stock price is $226.25, with a market capitalization of 546.85B. The stock trades at a price-to-earnings (P/E) ratio of 26.27 and offers a dividend yield of 2.3%.
On 2026-05-04, Johnson & Johnson(JNJ) shares started trading at $229.00, with intraday highs of — and lows of —.
Trading volume for Johnson & Johnson(JNJ) stock has reached 6.65K, versus its average volume of 7.88M.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $146.12.
Over the past 52 weeks, Johnson & Johnson(JNJ) stock has traded between a high of $251.71 and a low of $146.12.
JNJ News
In late April 2026, Johnson & Johnson reported strong first‑quarter results with revenue of US$24.06 billion, raised its full‑year sales outlook to US$100.30–US...
As the S&P 500 seeks the next leg higher, smart money might be moving toward healthcare, a sleeper sector of 2026. Still, the series of earnings upgrades, coupl...
The UK High Court has begun hearing what is expected to be the largest product liability case in UK history against Johnson & Johnson (NYSE:JNJ). Thousands of...
Analyst ratings
61%
of 28 ratingsMore JNJ News
Johnson & Johnson announced the appointment of Ryan Koors to Vice President, Investor Relations, effective May 7, 2026. Koors will report to Johnson & Johnson’s...
When you think of the path to wealth, you might immediately think of supercharged technology stocks -- players that may have delivered double or even triple-dig...
Johnson & Johnson has launched a head to head clinical trial comparing its Varipulse Pro pulsed field ablation system with Boston Scientific's FARAPULSE platfor...
Analyst Asad Haider from Goldman Sachs maintained a Buy rating on Johnson & Johnson and keeping the price target at $275.00. Claim 55% Off TipRanks Unlock hedge...
If you are asking whether Johnson & Johnson at around US$227.79 is still a reasonable entry or more of a hold for now, you will want to look closely at what the...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.